Korea vs United States of America: Proportion of isolates with decreased susceptibility or resistance
Korea
0
in 2018
United States of America
0.2907
in 2018
Korea rank
25th
United States of America rank
23rd
Proportion of isolates with decreased susceptibility or resistance over time
- Korea
- United States of America
How they compare
United States of America currently reports 0.2907 against 0 in Korea, a difference of 0.2907.
The two have swapped places 1 time across 9 shared years of data; in 2009 it was Korea ahead.
Korea ranks 25th and United States of America ranks 23rd of 51 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.27 | 0.7993 | 28.47 | Korea |
| 2010s | 15.66 | 0.4253 | 15.23 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Korea or United States of America?
- United States of America, at 0.2907 against 0 in Korea as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Korea and United States of America?
- 0.2907, with United States of America ahead.
- How many years of comparable data are there for Korea and United States of America?
- 9 years are reported by both, from 2009 to 2018.
- How do Korea and United States of America rank globally for proportion of isolates with decreased susceptibility or resistance?
- Korea ranks 25th and United States of America ranks 23rd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.